MiR-125b has long been deemed an onco-miR and tumor suppressive miR through targeting cell survival and apoptosis-related molecules, including p53, Bcl/Bak, and PI3K/Akt pathways [83]; the increased expression of miR-125b was reported in multiple types of human malignancy. The gene discussed is TP53; the disease is neoplasm.